Log In
BCIQ
Print this Print this
 

Parsortix cancer cell separation system

  Manage Alerts
Collapse Summary General Information
Company Parsortix Inc.
DescriptionMicroscale device that separates cells on the basis of size and/or surface interactions
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationCancer, Diagnostic
Indication DetailsDetect ovarian cancer; Harvest and analyze large cells such as circulating tumor cells (CTCs) from patient blood; Predict patient response to cancer treatment
Regulatory Designation
PartnerAngle plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today